does cigna insurance cover glp 1 drops coverage of GLP-1 obesity drugs for its own employees Cigna will stop covering GLP-1
Description
Based on the study results, in early March the FDA approved the use of injectable semaglutide to reduce the risk of cardiovascular death, myocardial infarction and stroke in adults with cardiovascular disease who are obese or overweight
May cause weight loss Neither medication is FDA-approved as a weight loss drug
Mansur RB, Di Vincenzo JD, Badulescu S, et al
Check out our comprehensive GLP-1 patient education hub, along with our YouTube Channel
For clients seeking comprehensive solutions for weight management, we offer insights into the use of medications such as Semaglutide, a GLP-1 receptor agonist commonly prescribed for weight loss
